IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Ceasing to be a substantial holder, page-53

  1. 17,528 Posts.
    lightbulb Created with Sketch. 422
    ▪ Response from EMA expected late Q4 CY2020
    ▪ Final Formulation Q4 CY2020
    ▪ Appointment of contract manufacturer Q4 CY2020
    ( as per agm presentation)

    Three bits of news due
    Leaving the run a bit late assuming all going to plan
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.